AzTrials
AzTrials

Isolated Gastrocnemius TightnessNCT07828392

Isolated Gastrocnemius Tightness and Tactile Sensitivity

An observational study of Isolated Gastrocnemius Tightness and Healthy Adult Participants, run by Nigde Omer Halisdemir University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Isolated gastrocnemius tightness is associated with various foot pathologies, particularly metatarsalgia and hallux valgus, and is also commonly observed in the general population. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
What is being tested?
Ankle Dorsiflexion Index
How many people
40 participants
Where
1 siteTurkey (Türkiye)
Study dates
8 Sep 2026to 1 Jan 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: It is planned to include a total of 40 participants in this study: 20 individuals with isolated gastrocnemius tightness and 20 without.

Who may be able to join

  • Adults aged 18-65 with or without isolated gastrocnemius tightness,
  • Individuals able to walk without experiencing pain

Who cannot join

  • Presence of neuromuscular disease,
  • Conditions affecting plantar tactile sensation, such as diabetes,
  • History of prior surgical procedures distal to the knee joint,
  • Any current or previous symptoms related to the foot or ankle region,
  • Presence of joint hypermobility,
  • Individuals who do not volunteer.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site, 1 recruiting
  • Nigde Omer Halisdemir University

    Niğde

    Rabia ZORLULAR, +5424362082, rabiaeraslan118@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Plantar Tactile Sensitivity Individuals With Isolated Gastrocnemius Tightness

Isolated gastrocnemius tightness is associated with various foot pathologies, particularly metatarsalgia and hallux valgus, and is also commonly observed in the general population. Limited ankle dorsiflexion, typically resulting from tightness of the gastrocnemius-soleus complex, may alter normal gait mechanics and lead to compensatory movement patterns that increase mechanical stress on the lower extremity. It is planned to include a total of 40 participants in this study: 20 individuals with isolated gastrocnemius tightness and 20 without. The participants' plantar tactile sensitivity and postural control characteristics will be compared.

Read the detailed description

Isolated gastrocnemius tightness has been widely studied in the adult population and is associated with various foot and ankle pathologies, such as plantar fasciitis, plantar ulcers, achilles tendinopathy, pes planus, and posterior tibial tendon dysfunction. However, no study evaluating plantar tactile sensation in individuals with isolated gastrocnemius tightness has been found in the existing literature. The findings of this study are expected to contribute to the existing literature regarding the relationship between isolated gastrocnemius tightness and plantar tactile sensation and postural control. Evaluating plantar tactile sensitivity and postural control together may help elucidate not only the mechanical effects of isolated gastrocnemius tightness on joint range of motion but also its potential effects related to sensory and postural control. This study plans to include 40 participants: 20 with isolated gastrocnemius tightness and 20 without. The participants' plantar tactile sensitivity and postural control characteristics will be compared.

Being tested
Ankle Dorsiflexion Index
Keywords
Isolated gastrocnemius tightness, tactile sensitivity, postural control, foot

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ankle Dorsiflexion IndexBehavioural

    First, the participant will be asked to move their knee forward-while keeping the heel of the tested foot in full contact with the ground and the foot aligned forward-until reaching the maximum dorsiflexion position possible without the heel lifting off the ground.

    Ankle dorsiflexion range of motion will be measured with the knee flexed at a minimum of 20°. Subsequently, the same assessment will be repeated with the knee in full extension (0°). Under both conditions, the maximum angular change occurring during the forward movement of the tibia relative to the starting position will be recorded as the ankle dorsiflexion range of motion.

    The difference between the mean dorsiflexion values obtained with the knee flexed at a minimum of 20° and in full extension will be calculated as the Ankle Dorsiflexion Index

Study groups in NCT07828392
Study groupRoleWhat they receive
individuals with isolated gastrocnemius tightnessThe difference between the mean dorsiflexion values obtained with the knee flexed at a minimum of 20° and in full extension will be calculated as the ankle dorsiflexion index (ADI): •Ankle dorsiflexion index = Dorsiflexion with knee at 20° flexion - dorsiflexion with knee in full extension The threshold value of ADI ≥10°, commonly used in the literature for classifying isolated gastrocnemius tightness, will be taken into account.
Receives: Behavioral: Ankle Dorsiflexion Index
individuals without isolated gastrocnemius tightnessThe difference between the mean dorsiflexion values obtained with the knee flexed at a minimum of 20° and in full extension will be calculated as the Ankle Dorsiflexion Index: For individuals without isolated gastrocnemius tightness, a threshold value of <10° for the Ankle Dorsiflexion Index will be considered.
Receives: Behavioral: Ankle Dorsiflexion Index

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Ankle dorsiflexion index

    First, the participant will be asked to move their knee forward-while keeping the heel of the tested foot in full contact with the ground and the foot aligned forward-until reaching the maximum dorsiflexion position possible without the heel lifting off the ground.

    Ankle dorsiflexion range of motion will be measured with the knee flexed at a minimum of 20°. Subsequently, the same assessment will be repeated with the knee in full extension (0°). Under both conditions, the maximum angular change occurring during the forward movement of the tibia relative to the starting position will be recorded as the ankle dorsiflexion range of motion.

    The difference between the mean dorsiflexion values obtained with the knee flexed at a minimum of 20° and in full extension will be calculated as the ankle dorsiflexion index.

    Measured: 6 months

  2. Assessment of postural control

    Postural control will be assessed using a force plate (KINVENT, France). Data will be transmitted to the force plate application via a Bluetooth connection. Prior to the actual measurements, participants will be informed about the force platform and the test conditions, and a practice trial will be conducted to familiarize them with the tests. Static postural control will be assessed under three different conditions: (1) standing on both feet with eyes open, (2) standing on both feet with eyes closed, and (3) standing on one foot with eyes open. In the assessment of postural control, the primary Center of Pressure parameters-mean Center of Pressure velocity, Center of Pressure path length, and sway area-were evaluated.

    Measured: 6 months

  3. Plantar tactile sensitivity

    Plantar tactile sensitivity will be assessed using Semmes-Weinstein monofilaments. During the assessment, participants will be positioned prone, with their feet hanging freely off the edge of the examination table and not touching any surface. The assessment will begin with the monofilament that applies the lowest force, and the procedure will progress to progressively thicker monofilaments until the participant perceives the stimulus. The lowest Semmes-Weinstein monofilament value perceived in these areas will be recorded as the plantar tactile sensation threshold. Lower perceived pressure values indicate higher tactile sensitivity in the sole of the participant's foot.

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Sep 2026
  2. Study start8 Sep 2026
  3. Primary completion1 Jan 2027 (estimated)
  4. Study completion1 Jan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07828392
Sponsor's protocol ID
Isolated Gastrocnemius
Status last verified
Sep 2026
First submitted
14 Sep 2026
Last updated
9 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • MARINACCIO L. [Frequency and clinical and histological significance of diseases of the uterus; critical and statistical observations on biopsies]. G Clin Med. 1953 Jul;34(7):788-823. No abstract available. Undetermined Language.

    PubMed 13095768
  • DeBack V. We have a part to play in changing the world: a conversation with Dr Vivien DeBack. Int Nurs Rev. 2002 Dec;49(4):199-201. doi: 10.1046/j.1466-7657.2002.00150.x. No abstract available.

    PubMed 12492940

Questions about this trial

What is this clinical trial studying?

An observational study of Isolated Gastrocnemius Tightness and Healthy Adult Participants, run by Nigde Omer Halisdemir University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 9 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Rabia ZORLULAR (+5424362082, rabiaeraslan118@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Ankle dorsiflexion index (time frame: 6 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07828392, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in